
|Videos|July 28, 2016
CINV: Understanding the Guidelines for Recommendations
Advertisement
James Natale, PharmD, BCOP, outlines the guidelines for acute and delayed emesis in patients receiving highly emetic chemotherapy versus moderately emetic chemotherapy.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Round-Up: Every Most Favored Nation Agreement With the Trump Administration
2
Study Finds Persistent Gaps in Diagnoses for Depression and Chronic Conditions After COVID-19
3
Dato-DXd Granted Priority Review as First-Line Therapy for Metastatic Triple-Negative Breast Cancer
4
Pharmacist-Led Atrial Fibrillation Clinic Accelerates Access to Physician Care
5


























